Concord Healthcare Group Co., Ltd. (HKG:2453)
1.090
0.00 (0.00%)
At close: Mar 27, 2026
Concord Healthcare Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -256.6 | -443.22 | -373.09 | -541.4 | -816.59 |
Depreciation & Amortization | 124.7 | 130.85 | 144.67 | 141.28 | 111.77 |
Other Amortization | - | 8.99 | 7.34 | 6.77 | 2.24 |
Loss (Gain) From Sale of Assets | - | -40.07 | - | 1.13 | -29.89 |
Asset Writedown & Restructuring Costs | - | 0.54 | 0.25 | 0.77 | - |
Loss (Gain) From Sale of Investments | - | -7.56 | - | - | - |
Loss (Gain) on Equity Investments | - | 1.31 | 1.74 | 0.22 | 0.16 |
Provision & Write-off of Bad Debts | - | 13.42 | 8.91 | 19.65 | -0.44 |
Other Operating Activities | 18.82 | 79.2 | 8.34 | 118.38 | 452.11 |
Change in Accounts Receivable | - | 10.92 | 24.46 | 8.44 | -79.57 |
Change in Inventory | - | 6.48 | 44.52 | -46.74 | 8.96 |
Change in Accounts Payable | - | -7.55 | -18.79 | 44.61 | 49.66 |
Change in Unearned Revenue | - | -9.51 | -41.34 | 42.17 | -31.12 |
Change in Other Net Operating Assets | - | 70.25 | 702.25 | 111.09 | 483.95 |
Operating Cash Flow | -113.08 | -185.96 | 509.24 | -93.64 | 151.23 |
Operating Cash Flow Growth | - | - | - | - | 198.66% |
Capital Expenditures | -88.1 | -314.16 | -177.93 | -82.03 | -477.19 |
Sale of Property, Plant & Equipment | - | - | - | 0.67 | 0.58 |
Cash Acquisitions | - | - | - | - | -106.43 |
Divestitures | - | 10.34 | - | - | -4.23 |
Sale (Purchase) of Intangibles | - | -11.27 | -5.82 | -2.65 | -45.63 |
Investment in Securities | - | -226.23 | - | - | -61.16 |
Other Investing Activities | 199.01 | -126.78 | -305.1 | -16.31 | -250.97 |
Investing Cash Flow | 110.91 | -668.09 | -488.84 | -100.33 | -945.04 |
Short-Term Debt Issued | - | - | - | 194.45 | 4.93 |
Long-Term Debt Issued | - | 2,230 | 185.32 | 243.15 | 345.69 |
Total Debt Issued | - | 2,230 | 185.32 | 437.6 | 350.61 |
Short-Term Debt Repaid | - | -26.91 | -193.71 | - | - |
Long-Term Debt Repaid | - | -1,529 | -219.65 | -98.86 | -123.63 |
Total Debt Repaid | - | -1,556 | -413.35 | -98.86 | -123.63 |
Net Debt Issued (Repaid) | - | 674.55 | -228.03 | 338.74 | 226.98 |
Issuance of Common Stock | - | 517.89 | 300 | - | 400 |
Other Financing Activities | 92.1 | -174.42 | -178.29 | -154.36 | -121.92 |
Financing Cash Flow | 92.1 | 1,018 | -106.32 | 184.37 | 505.06 |
Net Cash Flow | 89.93 | 163.97 | -85.92 | -9.59 | -288.75 |
Free Cash Flow | -201.18 | -500.12 | 331.31 | -175.67 | -325.96 |
Free Cash Flow Margin | -43.74% | -128.80% | 61.51% | -37.20% | -69.28% |
Free Cash Flow Per Share | -0.27 | -0.70 | 0.50 | -0.37 | - |
Cash Interest Paid | - | 162.35 | 161.2 | 137.38 | 118.64 |
Cash Income Tax Paid | - | 0.17 | 0.1 | -0.31 | 0.41 |
Levered Free Cash Flow | -281.63 | -480.98 | 183.76 | -3,877 | -518.67 |
Unlevered Free Cash Flow | -204.42 | -412.68 | 251.27 | -3,706 | -246.6 |
Change in Working Capital | - | 70.59 | 711.1 | 159.57 | 431.88 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.